Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns

The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.
By HEATHER MURPHY from NYT Health https://nyti.ms/2GlsXBT
via IFTTT
Genetics and Heredity, Tests (Medical), Breast Cancer, Ovarian Cancer
Source The New York Times
Làm đẹp Blog 247